These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for cervical neoplasia in Denmark. Kjaer SK APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118 [TBL] [Abstract][Full Text] [Related]
6. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515 [TBL] [Abstract][Full Text] [Related]
7. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127 [TBL] [Abstract][Full Text] [Related]
8. HPV-16-related proteins as the serologic markers in cervical neoplasia. Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998 [TBL] [Abstract][Full Text] [Related]
9. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction]. Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485 [TBL] [Abstract][Full Text] [Related]
11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512 [TBL] [Abstract][Full Text] [Related]
12. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150 [TBL] [Abstract][Full Text] [Related]
13. The association between pregnancy and human papilloma virus prevalence. Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203 [TBL] [Abstract][Full Text] [Related]
14. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer. Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121 [TBL] [Abstract][Full Text] [Related]
15. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer. Ogunbiyi OA; Scholefield JH; Robertson G; Smith JH; Sharp F; Rogers K Obstet Gynecol; 1994 Feb; 83(2):212-6. PubMed ID: 8290182 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Tsukui T; Hildesheim A; Schiffman MH; Lucci J; Contois D; Lawler P; Rush BB; Lorincz AT; Corrigan A; Burk RD; Qu W; Marshall MA; Mann D; Carrington M; Clerici M; Shearer GM; Carbone DP; Scott DR; Houghten RA; Berzofsky JA Cancer Res; 1996 Sep; 56(17):3967-74. PubMed ID: 8752165 [TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion. Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554 [TBL] [Abstract][Full Text] [Related]
18. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer. Caussy D; Marrett LD; Worth AJ; McBride M; Rawls WE CMAJ; 1990 Feb; 142(4):311-7. PubMed ID: 2154306 [TBL] [Abstract][Full Text] [Related]
20. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]